ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial

Transplant Proc. 2002 Sep;34(6):2201-2. doi: 10.1016/s0041-1345(02)03200-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Antilymphocyte Serum / therapeutic use*
  • Cause of Death
  • Drug Resistance
  • Follow-Up Studies
  • Graft Rejection / drug therapy
  • Graft Rejection / epidemiology
  • Graft Survival / physiology*
  • Humans
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Muromonab-CD3 / therapeutic use*
  • Survival Analysis
  • Time Factors

Substances

  • Adrenal Cortex Hormones
  • Antilymphocyte Serum
  • Muromonab-CD3